A multidisciplinary approach to mental illness: do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders.
Adolescent
Adult
Aged
Aging
/ physiology
Aging, Premature
/ etiology
Bipolar Disorder
/ complications
Case-Control Studies
Comorbidity
Cross-Sectional Studies
Depressive Disorder, Major
/ complications
Female
Gastrointestinal Microbiome
Humans
Inflammation
/ complications
Italy
Life Expectancy
Male
Mental Disorders
/ complications
Middle Aged
Research Design
Schizophrenia
/ complications
Telomere
Telomere Shortening
Young Adult
ELISA
aging
allostasis
biomarker
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
26 01 2020
26 01 2020
Historique:
entrez:
29
1
2020
pubmed:
29
1
2020
medline:
18
11
2020
Statut:
epublish
Résumé
Severe psychiatric disorders are typically associated with a significant reduction in life expectancy compared with the general population. Among the different hypotheses formulated to explain this observation, accelerated ageing has been increasingly recognised as the main culprit. At the same time, telomere shortening is becoming widely accepted as a proxy molecular marker of ageing. The present study aims to fill a gap in the literature by better defining the complex interaction/s between inflammation, age-related comorbidities, telomere shortening and gut microbiota in psychiatric disorders. A cross-sectional study is proposed, recruiting 40 patients for each of three different diagnostic categories (bipolar disorder, schizophrenia and major depressive disorder) treated at the Section of Psychiatry and at the Unit of Clinical Pharmacology of the University Hospital Agency of Cagliari (Italy), compared with 40 age-matched and sex-matched non-psychiatric controls. Each group includes individuals suffering, or not, from age-related comorbidities, to account for the impact of these medical conditions on the biological make-up of recruited patients. The inflammatory state, microbiota composition and telomere length (TL) are assessed. The study protocol was approved by the Ethics Committee of the University Hospital Agency of Cagliari (PG/2018/11693, 5 September 2018). The study is conducted in accordance with the principles of good clinical practice and the Declaration of Helsinki, and in compliance with the relevant Italian national legislation. Written, informed consent is obtained from all participants. Participation in the study is on a voluntary basis only. Patients will be part of the dissemination phase of the study results, during which a local conference will be organised and families of patients will also be involved. Moreover, findings will be published in one or more research papers and presented at national and international conferences, in posters or oral communications.
Identifiants
pubmed: 31988227
pii: bmjopen-2019-032513
doi: 10.1136/bmjopen-2019-032513
pmc: PMC7045141
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e032513Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
J Affect Disord. 2013 Jan 10;144(1-2):16-27
pubmed: 22749156
World Psychiatry. 2014 Jun;13(2):153-60
pubmed: 24890068
Cell. 2019 May 30;177(6):1600-1618.e17
pubmed: 31150625
Mol Psychiatry. 2013 Jun;18(6):666-73
pubmed: 22688187
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Psychiatry Res. 2018 Dec;270:41-49
pubmed: 30243131
Schizophr Res. 2018 Dec;202:37-45
pubmed: 30001973
PLoS Biol. 2016 Aug 19;14(8):e1002533
pubmed: 27541692
Schizophr Res. 2018 Nov;201:299-306
pubmed: 29859859
J Clin Endocrinol Metab. 2012 Jul;97(7):E1327-31
pubmed: 22539583
J Clin Psychiatry. 2006;67 Suppl 6:16-22
pubmed: 16848672
Arch Gen Psychiatry. 1988 Sep;45(9):789-96
pubmed: 3046553
Eur Neuropsychopharmacol. 2017 Jun;27(6):560-567
pubmed: 26621262
Nucleic Acids Res. 2013 Jan 7;41(1):e1
pubmed: 22933715
Lancet. 2018 Nov 24;392(10161):2299-2312
pubmed: 30396512
Lancet. 2016 Jul 2;388(10039):86-97
pubmed: 26777917
J Natl Cancer Inst. 2015 Apr 10;107(6):djv074
pubmed: 25862531
World Psychiatry. 2011 Feb;10(1):52-77
pubmed: 21379357
Curr Opin Psychiatry. 2015 Jan;28(1):1-6
pubmed: 25415497
JAMA. 2007 Oct 17;298(15):1794-6
pubmed: 17940236
Psychosom Med. 2016 Sep;78(7):776-87
pubmed: 27359174
Biol Psychiatry. 2006 Sep 1;60(5):432-5
pubmed: 16581033
Am J Med Genet B Neuropsychiatr Genet. 2017 Sep;174(6):651-660
pubmed: 28691768
Nucleic Acids Res. 2002 May 15;30(10):e47
pubmed: 12000852
Gut. 2011 Mar;60(3):307-17
pubmed: 20966022
Nat Rev Neurosci. 2012 Oct;13(10):701-12
pubmed: 22968153
Schizophr Res. 2018 Jul;197:470-477
pubmed: 29352709
Schizophr Res Cogn. 2014 Dec 08;1(4):187-192
pubmed: 29379752
Neurosci Biobehav Rev. 2015 Aug;55:333-64
pubmed: 25999120
Psychol Med. 2016 Aug;46(11):2337-49
pubmed: 27266474
Ageing Res Rev. 2016 Jan;25:55-69
pubmed: 26616852
Ann Gen Psychiatry. 2015 Feb 13;14:6
pubmed: 25699085
JAMA Psychiatry. 2015 Apr;72(4):334-41
pubmed: 25671328
Front Microbiol. 2018 Dec 19;9:3146
pubmed: 30619212
Schizophr Bull. 2018 Feb 15;44(2):398-408
pubmed: 29462455
Psychiatr Serv. 2009 Feb;60(2):147-56
pubmed: 19176408
Aging (Albany NY). 2018 Dec 18;10(12):4054-4065
pubmed: 30562162
Arch Gen Psychiatry. 2011 Mar;68(3):241-51
pubmed: 21383262
Psychopharmacology (Berl). 2016 May;233(9):1651-60
pubmed: 26988846
J Clin Psychiatry. 2002 Oct;63(10):942-7
pubmed: 12416605
Acta Psychiatr Scand Suppl. 2003;(416):16-23
pubmed: 12755850
Front Psychiatry. 2019 Feb 11;10:34
pubmed: 30804820
J Affect Disord. 2014 Dec;169:15-20
pubmed: 25128861
Immunol Invest. 2010;39(4-5):429-48
pubmed: 20450286
Cells. 2019 Jan 15;8(1):
pubmed: 30650526
J Behav Med. 1989 Apr;12(2):159-82
pubmed: 2668531